NDA 22282, held by Matrix Labs Ltd. Atazanavir Sulfate; Ritonavir.
As of Nov 13, 2026, NDA 22282 (Atazanavir Sulfate And Ritonavir), held by Matrix Labs Ltd, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 18, 2011 | Original applicationNew combination · Priority review | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Atazanavir Sulfate And Ritonavir300MG/100MG · tablet; oral | Atazanavir Sulfate; Ritonavir | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
